Fischer Imaging SenoScan
This article was originally published in The Gray Sheet
Executive SummaryFDA approval for the full-field digital mammography system is anticipated within the next 30 days following an "approvable" letter from the agency, announced July 20. Unlike GE Medical's Senographe 2000D full-field digital mammography system, approved February 2000, the SenoScan was not subject to advisory panel review
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.